Assessing Sexual Function in Women After Colorectal Cancer Surgery
Identification of the Most Suitable Questionnaire to Assess the Sexual Function of Women Living in France After Colorectal Cancer Surgery
This study is trying to find the best questionnaire to help women in France who have had rectal cancer surgery talk about their sexual health and quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University Hospital, Limoges Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Limoges) |
| Trial ID | NCT05391321 on ClinicalTrials.gov |
What this trial studies
This project aims to identify the most suitable questionnaire for assessing sexual function in women living in France who have undergone treatment for rectal cancer. It focuses on the significant impact of colorectal cancer management on women's quality of life, particularly regarding sexual health, which is often overlooked in clinical settings. The study will utilize four validated questionnaires translated into French and will involve a randomized double-blind methodology over a six-month period to determine which questionnaire is most acceptable and effective for this population.
Who should consider this trial
Good fit: Ideal candidates are women over 18 who have had rectal or recto-sigmoid cancer treated with sphincter preservation at least one year prior.
Not a fit: Patients with colon cancer, those who have undergone pelvic radiotherapy for non-colorectal conditions, or those with certain surgical histories will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the assessment and management of sexual health in women post-colorectal cancer treatment, enhancing their overall quality of life.
How similar studies have performed: While the approach of assessing sexual function post-cancer treatment is recognized, the specific adaptation of questionnaires for French-speaking women in this context is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * female * over 18 years of age * who have signed the informed consent to participate in the study * having had rectal or recto-sigmoid cancer at least one year before, whatever the stage, treated by rectal or recto-sigmoid resection with sphincter preservation * in the course of an eventual adjuvant treatment (chemotherapy or radiotherapy) * affiliated to the social security system of the health insurance, whatever the system Exclusion Criteria: * colon cancer * pelvic radiotherapy for a pathology other than colorectal cancer * rectal resection without restoration of continuity (Hartmann or abdominal-perineal amputation) * peritoneal carcinosis * colorectal resection for benign lesion * Inflammatory bowel disease (IBD) * emergency surgery
Where this trial is running
Limoges
- Limoges University Hospital — Limoges, France (Recruiting)
Study contacts
- Study coordinator: Muriel MATHONNET, MD
- Email: mathonnet@unilim.fr
- Phone: +33 55 05 67 01
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.